DRSK ETF Analysis: Aptus Defined Risk | BATS

Intermediate Core-Plus Bond | BATS, USA | Market Cap: 1.518m USD | 12M Return: 1.2% | Charts, Fundamentals & Technical Analysis

Corporate Bonds, U.S. Equities, Downside Hedging, Hybrid Allocation
Total Rating 36
Safety 72
Buy Signal -0.67
Intermediate Core-Plus Bond
Category Rotation: -2.9
TER: 0.78%
AUM: 1.52B
Avg Turnover: 3.48M
Risk 3d forecast
Volatility7.58%
VaR 5th Pctl1.28%
VaR vs Median-6.34%
Reward TTM
Sharpe Ratio-0.31
Rel. Str. IBD27.2
Rel. Str. Peer Group10
Character TTM
Beta0.381
Beta Downside0.302
Hurst Exponent0.482
Drawdowns 3y
Max DD9.28%
CAGR/Max DD0.81
CAGR/Mean DD3.94

Warnings

Choppy
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality

Not enough history
Description: DRSK Aptus Defined Risk

The Aptus Defined Risk ETF (DRSK) is an actively managed exchange-traded fund that employs a hybrid strategy combining fixed income and equity exposure. The fund allocates approximately 75% to 95% of its assets to investment-grade corporate bonds, with the remaining portion invested in U.S. stocks under a defined risk framework designed to limit downside exposure. The fund is classified within the Intermediate Core-Plus Bond category, reflecting its bond-heavy allocation.

DRSK launched in August 2018 and is listed on the BATS exchange. Its hybrid structure allows investors to gain traditional fixed income exposure while participating in equity markets with built-in risk management, typically through options-based hedging strategies used to define and cap potential losses on the equity portion of the portfolio.

Headlines to Watch Out For
  • Fed rate cuts pressure investment-grade corporate bond yields
  • Widening credit spreads weigh on intermediate core-plus bond returns
  • Rising hedging costs erode equity sleeve performance
What is the price of DRSK shares?

As of July 28, 2026, the stock is trading at USD 28.16 with a total of 157,600 shares traded. Over the past week, the price has changed by -1.19%, over one month by -2.22%, over three months by -1.12% and over the past year by +1.17%.

Current recommended Stop Loss: 27.90 (which is 0.9% or 1.6 ATR below the current price).

Is DRSK a buy, sell or hold?

Aptus Defined Risk has no consensus analysts rating.